Massivemarkets

Nasdaq: ASPE · Listed Oct 30, 2026

Aspen Neuroscience IPO

$12.25

▲ +2.08%today · -18.33% since the $15.00 IPO price

15-minute delayed · as of 7:32:35 PM EST on Nov 18, 2026

Aspen Neuroscience (ASPE) priced its IPO at $15.00 a share and has traded on Nasdaq since Oct 30, 2026.

Last session · Nov 18, 2026

VWAP 12.35open 12.00fell below the open · 9:40back above the open · 9:55fell below the open · 2:05back above the open · 2:10fell below the open · 3:00back above the open · 3:35fell below the open · 3:50back above the open · 4:00high 12.73low 11.90$12.23volume · rising bars above the line, falling bars below13.21K9:304:00
Market cap
$349.23M
from the ticker reference
Volume
269.33K
shares, regular session
VWAP
$12.35
the last price is -0.78% from the volume-weighted average
Day range
11.76–13.37
low to high

The trading numbers are from the last session, Nov 18, 2026.

The debut race

ASPE against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%ASPE -18.47%

The IPO scoreboard

ASPE against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

ASPE against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Aspen Neuroscience '26$140.63M-2.00%-7.13%-21.87%Not yet
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Aspen Neuroscience IPO offers 9.38M shares to raise $140.63M, before any underwriters' option.

$13$15$16$17$19
Expected price range
$15 to $17
IPO price
$15.00
Shares offered
9.38M
Money raised
$140.63M
Listing date
Oct 30, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Aspen Neuroscience$140.63M

Where ASPE ranks

Aspen Neuroscience's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • ASPE$349.23M

What comes after the IPO

Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.

  1. Oct 30, 2026

    First trade

    Prices, bars, and snapshots

  2. Nov 4, 2026 · est.

    Options list

    Option chain and open interest

  3. Nov 19, 2026 · est.

    First short interest

    Short interest and daily short volume

  4. Nov 24, 2026 · est.

    Quiet period ends

    Analyst ratings and price targets

  5. Feb 14, 2027

    First 13F deadline

    Which funds hold the stock

  6. Date not set

    First earnings

    Income statement and ratios

  7. Apr 27, 2027 · est.

    Lock-up expires

    Insider sales on Form 4

Filings and the company

What Aspen Neuroscience has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Aspen Neuroscience discloses to the SEC on Form 8-K.

  • Public offeringNov 2, 2026

    On November 2, 2026, the Company completed the IPO of 9,375,000 shares of the Company's common stock, par value $0.0001 per share, at a price to the public of $15.00 per share. The gross proceeds to the Company from the IPO were approximately $140.6 million, before deducting underwriting discounts and commissions and offering expenses payable by the Company.

About Aspen Neuroscience

Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.

Ticker
ASPE
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Listed
Oct 30, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Aspen Neuroscience IPO price?

$15.00 a share.

When did Aspen Neuroscience go public?

Aspen Neuroscience listed on Nasdaq on Oct 30, 2026 under the ticker ASPE.

How much did the Aspen Neuroscience IPO raise?

$140.63M, before any underwriters' option.

How did Aspen Neuroscience open on its first day?

ASPE first traded at $14.70, -2.00% from the IPO price of $15.00.

How did ASPE close on its first day?

Its last regular-session trade was $13.93, -7.13% from the IPO price of $15.00.

What was the ASPE first-day trading range?

$11.60 to $14.90 in the regular session.

How many ASPE shares traded on the first day?

1.12M shares in the regular session.

How many shares did Aspen Neuroscience sell in its IPO?

9.38M shares.

What exchange is ASPE listed on?

Aspen Neuroscience lists on Nasdaq under the ticker ASPE.

Are the prices on this page real time?

No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.

Build with Massive

Get the ASPE data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/ASPE/range/5/minute
Market cap/v3/reference/tickers/ASPE
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.